Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MARIAGER FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.9% 7.4% 3.2% 2.3% 1.9% 1.9% 18.2% 17.9%   Credit score (0-100)   71 33 54 64 69 69 8 8   Credit rating   A BB BBB BBB A A B B   Credit limit (kDKK)   0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,980 1,550 1,863 2,059 2,265 2,222 0.0 0.0   EBITDA   269 -432 161 285 192 137 0.0 0.0   EBIT   258 -450 124 224 132 77.6 0.0 0.0   Pre-tax profit (PTP)   251.7 -453.6 110.7 200.4 115.5 79.5 0.0 0.0   Net earnings   193.3 -356.4 79.2 155.0 89.1 59.2 0.0 0.0   Pre-tax profit without non-rec. items   252 -454 111 200 115 79.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   56.0 53.1 237 192 174 115 0.0 0.0   Shareholders equity total   328 -82.1 -3.0 152 241 300 175 175   Interest-bearing liabilities   0.0 86.2 381 172 3.8 4.1 0.0 0.0   Balance sheet total (assets)   580 455 680 622 612 642 175 175   Net Debt   -185 81.3 374 164 -109 -69.5 -175 -175     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,980 1,550 1,863 2,059 2,265 2,222 0.0 0.0   Gross profit growth   16.3% -21.7% 20.2% 10.5% 10.0% -1.9% -100.0% 0.0%   Employees   3 5 5 3 3 4 0 0   Employee growth %   0.0% 66.7% 0.0% -40.0% 0.0% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   580 455 680 622 612 642 175 175   Balance sheet change%   54.0% -21.5% 49.4% -8.5% -1.8% 5.0% -72.7% 0.0%   Added value   268.9 -432.3 160.9 285.3 193.1 136.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   24 -21 148 -107 -78 -118 -115 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.0% -29.0% 6.7% 10.9% 5.8% 3.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   53.9% -80.6% 20.6% 35.0% 22.1% 14.2% 0.0% 0.0%   ROI %   98.3% -162.1% 34.3% 46.9% 32.2% 21.3% 0.0% 0.0%   ROE %   74.9% -91.0% 13.9% 37.2% 45.3% 21.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   56.6% -15.3% -0.4% 24.4% 39.4% 46.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -68.7% -18.8% 232.6% 57.6% -56.8% -50.9% 0.0% 0.0%   Gearing %   0.0% -105.0% -12,843.0% 112.9% 1.6% 1.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 7.9% 6.3% 10.1% 24.1% 248.7% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.9 0.8 0.7 1.2 1.8 2.9 0.0 0.0   Current Ratio   2.1 0.9 0.8 1.3 2.0 3.0 0.0 0.0   Cash and cash equivalent   184.8 5.0 7.1 7.3 113.0 73.7 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   263.0 -21.2 -108.4 96.9 213.4 354.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   90 -86 32 95 64 34 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   90 -86 32 95 64 34 0 0   EBIT / employee   86 -90 25 75 44 19 0 0   Net earnings / employee   64 -71 16 52 30 15 0 0